Skip to main content
OpenTrials
Completed

NCT Number: NCT02112383

Group Versus Internet-based Cognitive Behavior Therapy for Procrastination

Procrastination is defined as a voluntarily delay of an intended course of action despite expecting to be worse-off for the delay, and is considered a persistent behavior pattern that can result in major psychological suffering. About one-fifth of the adult population and half of the student population are presumed having substantial difficulties due to recurrent procrastination in their everyday life. However, chronic and severe procrastinators seldom receive adequate care due to preconceptions and the lack of understanding regarding procrastination and the treatment interventions that are assumed beneficial. Cognitive behavior therapy is often deemed treatment of choice, although the evidence supporting its use is scarce, and only one randomized controlled trial has been performed. The primary aim of the current study is therefore to test the efficacy of cognitive behavior therapy delivered as either a group intervention or via the Internet. Participants will consist of students recruited through the Student Health Centre at Karolinska Institutet. A randomized controlled trial with a sample size of 100 participants divided into two conditions will be employed; a ten week Internet-based cognitive behavior therapy intervention, and an eight week group intervention based on cognitive behavior therapy. The current study is believed to result in two important findings. First, different interventions inherent in cognitive behavior therapy are assumed to be helpful for people suffering from problems caused by procrastination. Second, both a group intervention and an Internet-based cognitive behavior therapy intervention are presumed suitable for administering treatment for procrastination, which is considered highly important as the availability of adequate care is limited, particularly among students. The current study will increase the knowledge regarding the efficacy of different treatments of procrastination, as well as enhance the overall comprehension of the difficulties related to dilatory behavior.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Procrastination

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Student Health Centre at Karolinska Institutet.

Huddinge, 141 52, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fluent in Swedish
  • Computer with Internet access and a working email
  • Registered as students at one of the affiliated universities of the Student Health Centre at Karolinska Institutet
  • Primary difficulties related to chronic and severe procrastination

Exclusion criteria

  • Severe depression (30 points or more on MADRS-S)
  • Acute conditions in need of treatment; suicidal ideation, neuropsychiatric conditions (ADHD, ADD), misuse of alcohol or drugs, bipolar disorder, schizophrenia, and psychosis
  • Ongoing psychotherapy
  • Ongoing psychotropic medication (unless dose is stable three months prior the entering treatment)

Treatment and study plan

Cognitive behavior group therapy

Behavioral

For participants in the group intervention condition, the modules from a self-help treatment for procrastination will be delivered at four consecutive three-hour sessions at the Student Health Centre at Karolinska Institutet, with approximately two modules given at each session. The sessions will be spaced two weeks apart, during which participants are instructed to complete assignments related to the modules that were in focus of the previous session, e.g., goal-setting, time management, and behavioral experiments, which they are advised to present and discuss with the other participants.

Internet-based Cognitive Behavior Therapy

Behavioral

For participants in the Internet-based condition, the modules from a self-help treatment for procrastination will be distributed weekly during the treatment period, with one module given each week, i.e., ten weeks. In comparison to the group condition, participants will not receive a therapist contact or attend any sessions. In addition, the participants are expected to complete both the reading material and the assignments that are included in each module.

Primary outcomes

  1. Change from baseline on the Pure Procrastination Scale (PPS)

    Time frame: 0 weeks and 8 or 10 weeks

    The PPS features twelve items measuring the prevalence of procrastination.

  2. Change from baseline on the Pure Procrastination Scale (PPS)

    Time frame: 0 weeks and 24 weeks

    The PPS features twelve items measuring the prevalence of procrastination.

  3. Change from baseline on the Procrastination Assessment Scale for Students (PASS)

    Time frame: 0 weeks and 8 or 10 weeks

    The PASS features three items measuring difficulties of procrastination within six different domains of study related activities.

  4. Change from baseline on the Procrastination Assessment Scale for Students (PASS)

    Time frame: 0 weeks and 24 weeks

    The PASS features three items measuring difficulties of procrastination within six different domains of study related activities.

Secondary outcomes

  1. Change from baseline on the Montgomery-Åsberg Depression Rating Scale (MADRS-S)

    Time frame: 0 weeks and 8 or 10 weeks

    The MADRS-S is a self-report version of MADRS and features nine items measuring changes in mood, anxiety, sleeping patterns, appetite, concentration, initiative, emotional engagement, pessimism and attitude towards life.

  2. Change from baseline on the Montgomery-Åsberg Depression Rating Scale (MADRS-S)

    Time frame: 0 weeks and 24 weeks

    The MADRS-S is a self-report version of MADRS and features nine items measuring changes in mood, anxiety, sleeping patterns, appetite, concentration, initiative, emotional engagement, pessimism and attitude towards life.

  3. Change from baseline on the Generalized Anxiety Disorder Assessment (GAD-7)

    Time frame: 0 weeks and 8 or 10 weeks

    The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder.

  4. Change from baseline on the Generalized Anxiety Disorder Assessment (GAD-7)

    Time frame: 0 weeks and 24 weeks

    The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder.

  5. Change in baseline on the Symptoms Checklist 90 (SCL-90)

    Time frame: 0 weeks and 8 or 10 weeks

    SCL-90 features 90 items evaluating the participant's physical health and mental well-being, and consists of three global domains as well as nine subdomains.

  6. Change in baseline on the Symptoms Checklist 90 (SCL-90)

    Time frame: 0 weeks and 24 weeks

    SCL-90 features 90 items evaluating the participant's physical health and mental well-being, and consists of three global domains as well as nine subdomains.

Other outcomes

  1. Open-ended questions concerning adverse events

    Time frame: 4/5 weeks, 8/10 weeks, six-month follow-up

    The occurrence and characteristics of possible negative effects of treatment will be examined using open-ended questions, i.e., "did you experience any negative effects during treatment", including rating scales assessing the degree to which the adverse event has affected the participant.

Sponsors and collaborators

Lead sponsor

Stockholm University

Other

Collaborators

  • Karolinska Institutet

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Apr 11, 2014
Registry last updated
Mar 13, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.